Role of interleukin-1 in prion disease-associated astrocyte activation. - Wikidata - wikimedia - TriplyDB

Role of interleukin-1 in prion disease-associated astrocyte activation.

Role of interleukin-1 in prion disease-associated astrocyte activation.

http://www.wikidata.org/entity/Q38781760

about

A miRNA signature of prion induced neurodegeneration Prion pathogenesis in the absence of NLRP3/ASC inflammasomes Anti-prion activity of Brilliant Blue G NLRP3 inflammasome activation in macrophage cell lines by prion protein fibrils as the source of IL-1β and neuronal toxicity.Intracerebral administration of interleukin-12 (IL-12) and IL-18 modifies the course of mouse scrapie Genes contributing to prion pathogenesis Subtype and regional-specific neuroinflammation in sporadic creutzfeldt-jakob disease.Sod1 deficiency reduces incubation time in mouse models of prion disease The intricate mechanisms of neurodegeneration in prion diseases.Prion infection of mouse brain reveals multiple new upregulated genes involved in neuroinflammation or signal transduction.Prion disease induced alterations in gene expression in spleen and brain prior to clinical symptoms.Interleukin17A Promotes Postoperative Cognitive Dysfunction by Triggering β-Amyloid Accumulation via the Transforming Growth Factor-β (TGFβ)/Smad Signaling Pathway Identification of Major Signaling Pathways in Prion Disease Progression Using Network Analysis.Age-related comparisons of evolution of the inflammatory response after intracerebral hemorrhage in rats.Early cytokine elevation, PrPres deposition, and gliosis in mouse scrapie: no effect on disease by deletion of cytokine genes IL-12p40 and IL-12p35.Prion propagation and toxicity occur in vitro with two-phase kinetics specific to strain and neuronal type.Association mapping of genetic risk factors for chronic wasting disease in wild deer Systemic infections and inflammation affect chronic neurodegeneration.Investigation of mcp1 as a quantitative trait gene for prion disease incubation time in mouse.Effect of transplantation of bone marrow-derived mesenchymal stem cells on mice infected with prions.Measuring prions by bioluminescence imaging.Absence of CD14 delays progression of prion diseases accompanied by increased microglial activation.Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels Analysis of the hippocampal proteome in ME7 prion disease reveals a predominant astrocytic signature and highlights the brain-restricted production of clusterin in chronic neurodegeneration.Prion disease and the innate immune system.The Role of Microglia in Prion Diseases: A Paradigm of Functional Diversity.Microglia in prion diseases.Accelerated prion replication in, but prolonged survival times of, prion-infected CXCR3-/- mice.Association of Bcl-2 with misfolded prion protein is linked to the toxic potential of cytosolic PrP.Disease-associated protein seeding suggests a dissociation between misfolded protein accumulation and neurodegeneration in prion disease.GFAP expression in the rat brain following sub-chronic exposure to a 900 MHz electromagnetic field signal.IL-1 family members as candidate genes modulating scrapie susceptibility in sheep: localization, partial characterization, and expression.Comparative study of microglia activation induced by amyloid-beta and prion peptides: role in neurodegeneration.Decrease in neuroinflammation after immunisation with synthetic prion peptides in an animal model of scrapie.

P2860

Q21092168-E1A4BE41-04D9-4A75-8D42-5A29AD4ABADC Q27316552-1000CD74-13C8-4278-8469-47DBCD390EBA Q28484054-6FF29556-97C3-4394-9721-79D4EA3A7C8B Q30446504-02133D61-2C30-42FF-9117-4C811F041BB3 Q33267751-88B17931-1220-4894-8426-3BCE157DDB55 Q33687685-DA7DF87F-008D-4925-AA92-D8F50E184129 Q33997514-F730CA86-F590-4964-B706-837145916043 Q34563121-D804F53A-5991-4D34-B08E-E549F59E8A7F Q34664576-6828D7C6-AC86-4C22-848F-0665727E88C6 Q35115616-BC4BBE37-8302-4866-80FF-1CEFFF16505C Q35205306-676DFD4A-447E-4BF0-A0A6-D127C7FEF966 Q35824163-E585319B-5E98-46ED-BE1B-D37FB0B60750 Q35863572-3748570A-91F6-40BA-A480-D2532C8C9F68 Q36025116-596B7CF8-ED59-467F-98A0-72FCC1C14C3E Q36276458-2F6E55E6-AE12-4D8C-9EA8-E8B3699A4DA4 Q36607110-9D500199-24F1-4635-93DD-036CD5AB15CA Q36651717-EAE318B3-1D32-415E-B684-8E6692F9DC61 Q36707203-236B6593-15C3-4AD2-BCA5-F5FF5C06C28E Q36873781-5A7CB3F3-AC96-4CC6-93F1-0AF75369C18A Q37191835-9FB6CF2A-CED3-429B-B710-F97E3B37C476 Q37329528-B85B9339-7354-435E-9B52-E58E029C24C5 Q37336725-63FBDA00-8CD2-4EEE-A2C8-30240D32A994 Q37410864-2E28C8CE-DB17-41CA-9620-9D9F4BF7C86D Q37583628-5B681E74-8F39-4BA4-86AF-78FDF4BCB1D2 Q38076137-2798CD72-2DF6-45FE-B6C5-649C6370DBF4 Q39424451-CC1ED00F-42C0-4BA1-8437-C33E5E524779 Q40132256-132E7431-0FFC-44BC-B208-AF4DE962E67D Q41359654-25711887-7B1E-422B-973C-877EA01A3B76 Q42416416-74F6F240-97C7-4D92-9320-C3DEE9036D2D Q47663701-C0E8E3FE-E533-4C8D-B4C2-8B2E5235C735 Q48234676-8B95BF18-807B-4359-A704-E88E86588A1C Q48301105-47B9C3E8-7F3A-439D-8180-944A1AA9BFBF Q48570765-90DFF5CD-98EC-4707-836C-0A87DF078EA7 Q51794188-33B457F8-DC55-483F-B432-9D12A402EDF4

P2860

Role of interleukin-1 in prion disease-associated astrocyte activation.

http://www.wikidata.org/entity/Q38781760

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Role of interleukin-1 in prion disease-associated astrocyte activation.

@en

type

label

Role of interleukin-1 in prion disease-associated astrocyte activation.

@en

prefLabel

Role of interleukin-1 in prion disease-associated astrocyte activation.

@en

P1433

Q38781760-4C8EE9F5-D2CA-4408-9353-C83A92E73293

P1476

Q38781760-BD38A7B9-3339-4BC5-8FD1-4B20641A843B

P2093

Q38781760-3EC32CAB-2F23-4CA1-88F8-A8190357BDE2

Q38781760-4627DF0B-9B25-4925-B6EE-477568835E7C

Q38781760-5265B79E-D2B5-489B-A2EE-5DB0082E3943

Q38781760-58CB63EE-E80C-43C0-9137-D282DA06C086

Q38781760-59BDFFBF-7693-4FD3-924E-FE4EC568173F

Q38781760-7905DE7C-0093-4F09-89EA-D505FAF9B7E9

Q38781760-8F924785-62B7-4060-8EE5-92A92BC34C5E

Q38781760-95493501-420A-4F3E-9116-CE4EDD0A01A8

Q38781760-B47502DE-48DF-4976-B9E7-061A095B25BD

P2860

Q38781760-015A9F3F-449B-433A-8FCE-C23CC1E61F18

Q38781760-06AA44FD-F210-4231-B5AA-71DCF9739FEC

Q38781760-10E54FEE-34EE-4C89-8EF9-D70B851246EE

Q38781760-12E32E50-2BAF-4C49-9C16-D8A89954DFE4

Q38781760-1716C331-FA94-40FF-87D7-5DD86C1A3E6C

Q38781760-1B302A77-E9F3-41E5-9A77-FC8D682D00AB

Q38781760-1BAA5BA4-E664-4885-8113-23AA4343D492

Q38781760-1BACB4E6-191C-47B5-99BF-B9F81D561E8F

Q38781760-1CEB5C85-5212-424C-A487-CB4DD24388EE

Q38781760-1DC78876-735A-4FB5-8EF8-4F6E5EA0088C

P304

Q38781760-8952BA28-3DA5-41DA-9AB3-7075EA322565

P31

Q38781760-26D68C85-DB00-4D03-B5AE-6C7B4D85051F

P356

Q38781760-63F9A87E-7521-4DAC-8EE0-60DEF859D8BF

P407

Q38781760-AEE75CCA-1870-4EBA-BA7D-8585195BD007

P433

Q38781760-D5245D82-7607-41D2-BCCB-48917E190E84

P478

Q38781760-8A7FA5C5-D8E3-438B-9877-227D9B60E4F1

P577

Q38781760-6D66674C-0BDB-43A5-9230-4117A3A6CD47

P698

Q38781760-D08EAC0A-60A2-4659-8B20-2E8640A09CDD

P921

Q38781760-26bc4946-27f8-40db-9454-710e653cf445

Q38781760-D24F493A-C290-49C1-BC71-4C4F6414F5A2

P932

Q38781760-859611D0-A38F-483A-8D97-DB767013390D

P356

S0002-9440(10)63331-7

P1433

The American Journal of Pathology

P1476

Role of interleukin-1 in prion disease-associated astrocyte activation.

@en

P2093

Anja Schwarz

http://www.w3.org/2001/XMLSchema#string

Constanze Riemer

http://www.w3.org/2001/XMLSchema#string

Dietrich Simon

http://www.w3.org/2001/XMLSchema#string

Julia Schultz

http://www.w3.org/2001/XMLSchema#string

Manfred Kopf

http://www.w3.org/2001/XMLSchema#string

Markus Otto

http://www.w3.org/2001/XMLSchema#string

Michael Baier

http://www.w3.org/2001/XMLSchema#string

Michael Burwinkel

http://www.w3.org/2001/XMLSchema#string

Sabine Neidhold

http://www.w3.org/2001/XMLSchema#string

P2860

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Cytokines and acute neurodegeneration

Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease

Expression and modulation of IFN-gamma-inducible chemokines (IP-10, Mig, and I-TAC) in human brain endothelium and astrocytes: possible relevance for the immune invasion of the central nervous system and the pathogenesis of multiple sclerosis

Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology.

Inducible cytokine gene expression in the brain in the ME7/CV mouse model of scrapie is highly restricted, is at a strikingly low level relative to the degree of gliosis and occurs only late in disease.

Interleukin (IL)-10 inhibits IL-6 production in microglia by preventing activation of NF-kappaB.

P304

671-678

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)63331-7

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

165

http://www.w3.org/2001/XMLSchema#string

P577

2004-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15277240

http://www.w3.org/2001/XMLSchema#string

P921

Prion protein family

P932

1618583

http://www.w3.org/2001/XMLSchema#string